Still enjoying life eight years after being given a six percent chance of surviving metastatic melanoma, Nancy Calder joins a new NCCC clinical trial to contribute to finding a cure.
NCCC's Blood and Marrow Transplant Program now safely offers haploidentical (half-match) stem cell transplants to patients with blood cancers and disorders.
In 2011, a persistent sore throat was the beginning of journey that led Gerrie Scott to Dartmouth-Hitchcocks Norris Cotton Cancer Center and a difficult diagnosis of carcinoma of the tongue.
Learn how NCCC's Kerrington Smith, MD (Surgical Oncology) and Peter Kaufman, MD (Hematology Oncology) are advancing cancer research as the most recent Steven B. Currier Clinical Oncology Scholars.
Michael Marcroft has gotten to know NCCC as a volunteer and as a supporter of his father and three wives who all battled cancer. Recently, he acquired a new perspective: that of a patient.
Artificial intelligence for lung cancer screening, uncovering a new tumor-killing immune cell, and the world's first DNA printer: all funded with Prouty dollars